San Diego, January 24, 2026
Revelation Biosciences Inc. has finalized an agreement to exercise certain warrants, projected to generate around $11 million in gross proceeds. This strategic move aims to enhance its clinical development programs and support corporate activities. With a reduced exercise price of $0.86 per share, the closing of the offering is expected by January 26, 2026. The funds will bolster the company’s research efforts and represent the entrepreneurial spirit thriving in San Diego’s health solutions sector.
San Diego, CA – Revelation Biosciences Inc. (NASDAQ: REVB), a clinical-stage life sciences company dedicated to rebalancing inflammation, has recently sealed a definitive agreement for the immediate exercise of certain outstanding warrants. This strategic move is projected to raise about $11 million in gross proceeds for the company. The warrants, originally issued on September 11, 2025, are being exercised at an attractive reduced price of $0.86 per share. The closing of this offering is expected around January 26, 2026, pending customary closing conditions.
Revelation Biosciences plans to allocate the net proceeds from this transaction to further develop its clinical programs and support general corporate activities. Roth Capital Partners is serving as the financial advisor for this important transaction. Such initiatives reflect a growing commitment from local businesses to innovate and advance health solutions in San Diego, showcasing the potential of entrepreneurial spirit to enrich the community’s economy.
The warrant exercise comes as the company looks to build on its previous progress made in September 2025 when Revelation Biosciences entered into warrant inducement letters with particular institutional investors. This move incentivized the exercise of approximately 13,065,000 Class H Common Stock Warrants, which can convert to 4,355,000 shares of common stock at an exercise price of $2.20 per share. As part of the agreement, the company issued new Class I Common Stock Warrants, further demonstrating a commitment to fostering investor relationships and strengthening its capital base.
Proceeds and Future Plans
The anticipated $11 million raised from the current warrant exercise will significantly enhance Revelation Biosciences’ capacity to advance its clinical development programs. The planned investment is expected to facilitate critical research and development phases, eventually leading to regulatory approvals and commercial sales of its innovative products.
Revelation Biosciences is dedicated to moving its product candidates through clinical trials, highlighting the vital role that small and innovative companies play in the broader landscape of health and medicines. By working to address critical health concerns through inflammation management, the company embodies a model of resilience that is crucial in today’s competitive business environment.
Business Environment and Regulation
San Diego’s business landscape thrives on innovation and entrepreneurship. The reduced regulatory red tape has enabled local firms like Revelation Biosciences to attract capital investment and push onward with their ambitious research agendas. A favorable business environment encourages not just large enterprises, but also small startups to flourish, paving the way for significant contributions to the San Diego economy. Companies that focus on solving health challenges, such as Revelation Biosciences, reflect what can happen when entrepreneurship is encouraged and supported.
Conclusion
Revelation Biosciences Inc.’s recent actions underscore the opportunities found within San Diego’s life sciences sector. By exercising warrants to secure essential funding, the company positions itself for growth and innovation in an increasingly important industry. As we watch the developments unfold, it serves as a reminder of the role that local businesses play in driving economic growth and enhancing community health solutions. Residents are encouraged to support such initiatives and stay engaged with the economic vibrancy in San Diego, California.
FAQ
What is the purpose of Revelation Biosciences’ recent warrant exercise?
The company has entered into a definitive agreement for the immediate exercise of certain outstanding warrants, expected to generate approximately $11 million in gross proceeds. The net proceeds are intended to advance its clinical development programs and support general corporate purposes.
When is the closing of this offering expected?
The closing of this offering is anticipated on or about January 26, 2026, pending customary closing conditions.
Who is serving as the financial advisor for this transaction?
Roth Capital Partners is serving as the financial advisor for this transaction.
What was the exercise price of the warrants being exercised?
The warrants are being exercised at a reduced price of $0.86 per share.
What is the duration of the newly issued Class I Common Stock Warrants?
The newly issued Class I Common Stock Warrants are exercisable for a period of five years from the date of stockholder approval.
Key Features
| Feature | Details |
|---|---|
| Transaction Type | Exercise of outstanding warrants |
| Gross Proceeds | Approximately $11 million |
| Exercise Price | $0.86 per share |
| Closing Date | On or about January 26, 2026 |
| Financial Advisor | Roth Capital Partners |
| Use of Proceeds | Advance clinical development programs and support general corporate purposes |
| Duration of New Warrants | Five years from the date of stockholder approval |
Deeper Dive: News & Info About This Topic
HERE Resources
Author: STAFF HERE SAN DIEGO WRITER
The SAN DIEGO STAFF WRITER represents the experienced team at HERESanDiego.com, your go-to source for actionable local news and information in San Diego, San Diego County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Comic-Con International, San Diego County Fair, and San Diego Pride Festival. Our coverage extends to key organizations like the San Diego Regional Chamber of Commerce and United Way of San Diego County, plus leading businesses in biotechnology, healthcare, and technology that power the local economy such as Qualcomm, Illumina, and Scripps Health. As part of the broader HERE network, including HEREAnaheim.com, HEREBeverlyHills.com, HERECostaMesa.com, HERECoronado.com, HEREHollywood.com, HEREHuntingtonBeach.com, HERELongBeach.com, HERELosAngeles.com, HEREMissionViejo.com, and HERESantaAna.com, we provide comprehensive, credible insights into California's dynamic landscape.
